JP Morgan Chase
MAIA icon

JP Morgan Chase’s MAIA Biotechnology MAIA Stock Holding History

JP Morgan Chase’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50
Closed -$90 – 7602
2025
Q2 		$90 Buy
50
+8
+19% +$14 ﹤0.01% 6850
2025
Q1 		$64 Sell
42
-3
-7% -$6 ﹤0.01% 6937
2024
Q4 		$89 Sell
45
-2
-4% -$5 ﹤0.01% 7024
2024
Q3 		$132 Buy
47
+6
+15% +$19 ﹤0.01% 6963
2024
Q2 		$140 Buy
41
+3
+8% +$9 ﹤0.01% 6836
2024
Q1 		$84 Sell
38
-40
-51% -$60 ﹤0.01% 6938
2023
Q4 		$91 Buy
78
+67
+609% +$108 ﹤0.01% 7134
2023
Q3 		$24 Buy
+11
New +$22 ﹤0.01% 7137

Other funds holding MAIA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return

JP Morgan Chase's MAIA Position: Q3 2025 in Review

JP Morgan Chase sold out of MAIA Biotechnology (MAIA) in Q3 2025, closing a stake of 50 shares — an estimated $90 sold.

JP Morgan Chase first reported a position in MAIA in Q3 2023 and held it in 8 quarters. The position peaked at $140 in Q2 2024. 19 funds tracked by Wall St. Rank hold MAIA as of Q3 2025.

  • JP Morgan Chase reported no remaining MAIA Biotechnology position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 50 MAIA Biotechnology shares in Q3 2025, an estimated $90.
  • JP Morgan Chase first reported a position in MAIA Biotechnology in Q3 2023 and held it in 8 quarters.
  • JP Morgan Chase's MAIA Biotechnology position peaked at $140 in Q2 2024.
  • 19 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.